The use of tranexamic acid in revision total hip arthroplasty: A pilot study

Current Orthopaedic Practice

Volumn 20, Issue 2, 2009, Pages 152-156

  Gill, J Brian ^a   Chase, Emily ^b   Rosenstein, Alexander D ^c  

^a Nebraska Foundation for Spinal Research   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Blood loss; Blood transfusions; Randomized controlled trial; Revision total hip arthroplasty; Tranexamic acid

Indexed keywords

HEMOGLOBIN; PLACEBO; TRANEXAMIC ACID; WARFARIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG USE; FEMALE; HEMATOCRIT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; PILOT STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS;

EID: 70349243602     PISSN: 19407041     EISSN: 19417551     Source Type: Journal    
DOI: 10.1097/BCO.0b013e318191ebc0     Document Type: Article

References (32)

1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg. 2007; 89(A):780-785.
2. Keating EM. Blood Transfusion. In: Koval KJ, editor. Orthopaedic Knowledge Update 7. Rosemont, Illinois: American Academy of Orthopaedic Surgeons; 2002. p. 51.
3. Benoni G, Fredin H, Knebel R, Nilsson P. Blood conservation with tranexamic acid in total hip arthroplasty: A randomized, doubleblind study in 40 primary operations. Acta Orthop Scand. 2001; 72:442-448.
4. Ekback G, Axelsson K, Ryttberg L, et al. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg. 2000; 91:1124-1130.
5. Garcia-Huete L, Domenech P, Sabate A, et al. The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: A randomized clinical study. Hepatology. 1997; 26:1143-1148.
6. Gill JB, Rosenstein A. The use of antifibrinolytic agents in total hip arthroplasty. J Arthroplasty. 2006; 21:869-873.
7. Hayes A, Murphy DB, McCarroll M. The efficacy of single-dose aprotinin 2 million KIU in reducing blood loss and its impact on the incidence of deep venous thrombosis in patients undergoing total hip replacement surgery. J Clin Anesth. 1996; 8:357-360.
8. Hiippala ST, Strid LJ, Wennerstrand MI, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg. 1997; 84:839-844.
9. Ho KM, Ismail H. Use of intravenous tranexamic acid to reduce allogenic blood transfusion in total hip and knee arthroplasty: A meta-analysis. Anaesth Intensive Care. 2003; 31:529-537.
10. Husted H, Blond L, Sonne-Holm S, et al. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: A prospective randomized double-blind study in 40 patients. Acta Orthop Scand. 2003; 74:665-669.
11. Ido K, Neo M, Asada Y, et al. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg. 2000; 120:518-520.
12. Janssens M, Joris J, David JL, Lemaire R, Lamy M. High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology. 1994; 80:23-29.
13. Jeserschek R, Clar H, Aigner C, et al. Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery: A prospective, double-blind, randomised and placebo-controlled study. J Bone Joint Surg. 2003; 85(B):174-177.
14. Kasper SM, Elsner F, Hilgers D, Grond S, Rutt J. A retrospective study of the effects of small-dose aprotinin on blood loss and transfusion needs during total hip arthroplasty. Eur J Anaesthesiol. 1998; 15:669-675.
15. Kokoszka A, Kuflik P, Bitan F, Casden A, Neuwirth M. Evidencebased review of the role of aprotinin in blood conservation during orthopaedic surgery. J Bone Joint Surg. 2005; 87(A):1129-1136.
16. Lemay E, Guay J, Cote C, Roy A. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth. 2004; 51:31-37.
17. Murkin JM, Shannon NA, Bourne RB, et al. Aprotinin decreases blood loss in patients undergoing revision or bilateral total hip arthroplasty. Anesth Analg. 1995; 80:343-348.
18. Niskanen RO, Korkala OL. Tranexamic acid reduces blood loss in cemented hip arthroplasty-randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthopaedica. 2005; 76:829-832.
19. Ozier Y, Schlumberger S. Pharmacological approaches to reducing blood loss and transfusions in the surgical patient. Can J Anesth. 2006; 53:S21-S29.
20. Tanaka N, Sakahashi H, Sato E, Hirose K. Timing of the administration of tranexamic acid for maximumreduction in blood loss in arthroplasty of the knee. J Bone Joint Surg. 2001; 83(B):702-705.
21. Yamasaki S, Masuhara K, Fuji T. Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases. Int Orthop. 2004; 28:69-73.
22. Zufferey P, Merquio F, Laporte S, et al. Do antifibrinolytics reduce allogenic blood transfusion in orthopaedic surgery? Anesthesiology. 2006; 105:1034-1046.
23. Yamasaki S, Masuhara K, Fuji T. Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty. J Bone Joint Surg. 2005; 87(A):766-770.
24. Murkin JM, Haig GM, Beer KJ, et al. Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement. J Bone Joint Surg. 2000; 82(A):675-684.
25. Mangano DT, Miao Y, Vuylsteke A, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007; 297:471-479.
26. Walsh TS, McClelland DB. When should we transfuse critically ill and perioperative patients with known coronary artery disease. Br J Anaesth. 2003; 6:90.
27. Mannucci PM. Hemostatic drugs. N Engl J Med. 1998; 339:245.
28. Nilsson IM. Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol. 1980; 14:41.
29. Nuttall GA, Oliver WC, Ereth MH, et al. Schaff HV: Comparison of blood-conservation strategies in cardiac surgery patients at high risk for bleeding. Anesthesiology. 2000; 92:674-682.
30. Phillips SJ, Chavan R, Porter ML, et al. Does salvage and tranexamic acid reduce the need for blood transfusion in revision hip surgery? J Bone Joint Surg. 2006; 88(B):1141-1142.
31. Benoni G, Lethagen S, Nilsson P, Fredin H. Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthop Scand. 2000; 71:250-254.
32. Garneti N, Field J. Bone bleeding during total hip arthroplasty after administration of tranexamic acid. J Arthroplasty. 2004; 19:488-492.